KDM3A Inhibition Ameliorates Hyperglycemia-Mediated Myocardial Injury by Epigenetic Modulation of Nuclear Factor Kappa-B/P65.

KDM3A Inhibition Ameliorates Hyperglycemia-Mediated Myocardial Injury by Epigenetic Modulation of Nuclear Factor Kappa-B/P65. — المؤلف: Zhang, Bofang — Frontiers in cardiovascular medicine 2022

المؤلف
Zhang, Bofang
النشر
Frontiers in cardiovascular medicine 2022
الوصف
870999 p.